Reinsurance Group stock rating cut to Market Perform

Raymond James downgraded Reinsurance Group of America (RGA) from Strong Buy to Market Perform, citing increased competition in in-force blocks and pension risk transfers, as well as a temporary pause in the U.S. jumbo PRT market. While RGA reported better-than-expected Q1 2025 earnings of $5.66 per share, revenue missed estimates at $5.26 billion, though consolidated net premiums increased 13% year-over-year; Raymond James also slightly adjusted its EPS estimates for 2025-2027, reflecting a recalibrated outlook on the company's future earnings.

Analysis

Reinsurance Group of America (RGA) has been downgraded by Raymond James from Strong Buy to Market Perform, reflecting concerns over heightened competition for in-force blocks and pension risk transfers (PRTs) from approximately 20-25 Bermuda-based firms, a temporary pause in the U.S. jumbo PRT market, and diminishing returns on UK buy-in PRTs. This outlook led Raymond James to slightly adjust its EPS estimates for 2026 to $25.47 and 2027 to $27.40, while the 2025 estimate of $23.14 remains unchanged. Despite these challenges, RGA reported Q1 2025 adjusted operating earnings of $5.66 per share, exceeding the $5.44 forecast, and saw a 13% year-over-year increase in consolidated net premiums, although Q1 revenue of $5.26 billion missed the $5.36 billion expectation. The company, trading at $199.61, boasts $21.03 billion in revenue over the last twelve months and a 33-year history of dividend payments with 15 consecutive years of increases, yet InvestingPro data indicates weak gross profit margins at 12.73%. Positive catalysts include anticipated strong UK PRT sales, growth in Asian markets, and an expected $70 million pretax contribution from the Equitable transaction in 2025, with InvestingPro's Fair Value analysis suggesting RGA may be undervalued.

Key Decisions for Investors

• Investors should closely monitor RGA's ability to navigate the heightened competitive pressures in the PRT market and its impact on future growth and profitability, particularly in light of the analyst downgrade.
• Evaluate the company's consistent dividend payments and recent earnings outperformance against the backdrop of its reported weak gross profit margins of 12.73% and the Q1 revenue shortfall.
• Consider the potential undervaluation suggested by InvestingPro and positive operational developments, such as UK PRT sales and the Equitable transaction, while weighing the risks highlighted by Raymond James' revised earnings outlook and the challenging market conditions.